0.55
price down icon8.33%   -0.05
after-market 시간 외 거래: .54 -0.01 -1.82%
loading
전일 마감가:
$0.60
열려 있는:
$0.59
하루 거래량:
300.82K
Relative Volume:
0.28
시가총액:
$53.08M
수익:
-
순이익/손실:
$-20.31M
주가수익비율:
-2.0794
EPS:
-0.2645
순현금흐름:
$-21.07M
1주 성능:
-12.60%
1개월 성능:
-16.77%
6개월 성능:
-36.85%
1년 성능:
-48.11%
1일 변동 폭
Value
$0.55
$0.5999
1주일 범위
Value
$0.55
$0.647
52주 변동 폭
Value
$0.55
$1.53

Oncolytics Biotech Inc Stock (ONCY) Company Profile

Name
명칭
Oncolytics Biotech Inc
Name
전화
-
Name
주소
-
Name
직원
0
Name
트위터
@oncolytics
Name
다음 수익 날짜
2025-03-07
Name
최신 SEC 제출 서류
Name
ONCY's Discussions on Twitter

ONCY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ONCY
Oncolytics Biotech Inc
0.55 53.08M 0 -20.31M -21.07M -0.2645
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-10-06 개시 Maxim Group Buy
2021-02-17 개시 H.C. Wainwright Buy

Oncolytics Biotech Inc 주식(ONCY)의 최신 뉴스

pulisher
Mar 16, 2025

Oncolytics Biotech’s Financial Stability at Risk: Urgent Need for New Financing - MSN

Mar 16, 2025
pulisher
Mar 14, 2025

FY2027 EPS Estimate for Oncolytics Biotech Lifted by Analyst - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

What is Leede Financial’s Estimate for ONCY FY2025 Earnings? - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

TSE:ONC FY2025 EPS Estimate Lifted by Leede Financial - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

HC Wainwright Has Bearish Forecast for ONCY FY2029 Earnings - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

HC Wainwright Cuts Earnings Estimates for Oncolytics Biotech - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Oncolytics Biotech® to Participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference - GuruFocus.com

Mar 12, 2025
pulisher
Mar 12, 2025

Biotech Advancing Pivotal Phase III Breast Cancer Trial - Streetwise Reports

Mar 12, 2025
pulisher
Mar 11, 2025

Bridgewater Systems and Oncolytics Biotech Inc. Under Current Evaluation - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 11, 2025

Oncolytics Biotech (NASDAQ:ONCY) Given Buy Rating at HC Wainwright - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Oncolytics Biotech (NASDAQ:ONCY) Price Target Cut to $3.00 by Analysts at Maxim Group - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Oncolytics Biotech: Continuing To Justify The Negativity - Seeking Alpha

Mar 11, 2025
pulisher
Mar 10, 2025

Oncolytics Biotech’s Promising Advancements and Strategic Developments Drive Buy Rating - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Oncolytics price target lowered to $3 from $5 at Maxim - TipRanks

Mar 10, 2025
pulisher
Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion-And the Stocks Leading the Charge - The Malaysian Reserve

Mar 08, 2025
pulisher
Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge - PR Newswire

Mar 08, 2025
pulisher
Mar 08, 2025

Sun Valley buying at Canagold Resources (CCM) - The Globe and Mail

Mar 08, 2025
pulisher
Mar 08, 2025

Earnings call transcript: Oncolytics Biotech Q4 2024 shows strategic focus By Investing.com - Investing.com Canada

Mar 08, 2025
pulisher
Mar 08, 2025

Oncolytics Biotech Inc (ONCY) Q4 2024 Earnings Call Highlights: - GuruFocus.com

Mar 08, 2025
pulisher
Mar 08, 2025

Oncolytics Biotech Inc - MENAFN.COM

Mar 08, 2025
pulisher
Mar 08, 2025

Oncolytics Biotech Inc (ONCY) Q4 2024 Earnings Call Highlights: Promising Cancer Study Results ... - Yahoo Finance

Mar 08, 2025
pulisher
Mar 07, 2025

Oncolytics Biotech Advances Cancer Trials with Promising Results - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Oncolytics Biotech’s Earnings Call: Clinical Progress Amid Challenges - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Stocks In Play: Oncolytics Biotech Inc - Barchart

Mar 07, 2025
pulisher
Mar 07, 2025

Stocks In Play: Oncolytics Biotech Inc. - Barchart

Mar 07, 2025
pulisher
Mar 07, 2025

Oncolytics Biotech Inc. - Baystreet.ca

Mar 07, 2025
pulisher
Mar 07, 2025

Earnings call transcript: Oncolytics Biotech Q4 2024 shows strategic focus - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Oncolytics Biotech® Reports Highlights And Financial Results For Q4 And Year-End 2024 - Barchart

Mar 07, 2025
pulisher
Mar 07, 2025

Oncolytics Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 07, 2025
pulisher
Mar 07, 2025

From Clinical Trials to the Market: Cancer Stocks With Big Potential in 2025 - Baystreet.ca

Mar 07, 2025
pulisher
Mar 07, 2025

Oncolytics reports Q4 EPS (10c) vs. (5c) last year - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024 - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Earnings Scheduled For March 7, 2025 - Benzinga

Mar 07, 2025
pulisher
Mar 05, 2025

Oncolytics Biotech (ONCY) Loses -9.34% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Mar 05, 2025
pulisher
Mar 05, 2025

Oncolytics Biotech Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView

Mar 05, 2025
pulisher
Mar 03, 2025

Oncolytics Biotech(R) Announces Abstract Published for the 61st Annual Meeting & Exposition of the American Society of Hematology - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 02, 2025

Oncolytics Biotech(R) Presents Clinical Data Highlighting the Effectiveness of Intravenous Delivery to and Replication of Pelareorep in Tumors - ACCESS Newswire

Mar 02, 2025
pulisher
Feb 28, 2025

Oncolytics Biotech(R) Announces Abstract Outlining Potential New Biomarker to be Presented at the 2020 Gastrointestinal Cancers Symposium - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Oncolytics Biotech(R) Announces Spanish Regulatory Approval of AWARE-1 Window of Opportunity Study in Breast Cancer - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Oncolytics Biotech (ONCY) to Release Quarterly Earnings on Friday - Defense World

Feb 28, 2025
pulisher
Feb 28, 2025

Oncolytics Biotech(R) Announces Voting Results from the Annual General Meeting of Shareholders - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Oncolytics Biotech (ONCY) Projected to Post Earnings on Friday - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Oncolytics Biotech(R) Announces First Patient Treated in Company's AWARE-1 Window of Opportunity Study of Pelareorep in Breast Cancer - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 - The Malaysian Reserve

Feb 27, 2025
pulisher
Feb 27, 2025

Oncolytics Biotech CEO, Matt Coffey, Honored with Scientific Achievement and Innovation Award by BioAlberta - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Oncolytics Biotech(R) Announces Pricing of Its Public Offering of Common Share and Warrants - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Oncolytics Biotech(R) Announces Upcoming Conference Participation - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Oncolytics Biotech(R) to Host Key Opinion Leader Meeting on the Emerging Role of Biomarkers and Oncolytic Viruses in the Treatment of Cancer - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

World Cancer Day Sparks Big Questions About Pollution, Genetics, and Innovation - Baystreet.ca

Feb 27, 2025
pulisher
Feb 25, 2025

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights - The Globe and Mail

Feb 25, 2025
pulisher
Feb 25, 2025

Oncolytics Biotech to Discuss 2024 Financial Results and Operational Highlights - TipRanks

Feb 25, 2025

Oncolytics Biotech Inc (ONCY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
자본화:     |  볼륨(24시간):